Application Of The FLT3 Test In Newly Diagnosed AML Patients

Editor

6 years ago

James McCloskey, MD Interim Chief, Division of Leukemia, Hackensack University Medical Center, John Theurer Cancer Center Discusses Application Of The FLT3 Test In Newly Diagnosed AML Patients At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com